MedTrace Logo

LiquiBand® Exceed™ and LiquiBand® Rapid™ for General Surgery Procedures

NCT04740775 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2025-01-28

No results posted yet for this study

Summary

The purpose of this post market study is to evaluate the performance and safety of LiquiBand® Exceed™ and LiquiBand® Rapid™ for closure of surgical incisions associated with abdominal surgery.

Conditions

  • Surgical Wound

Interventions

DEVICE

LiquiBand Exceed

Cyanoacrylate glue for closure of surgical wounds

DEVICE

LiquiBand Rapid

Cyanoacrylate glue for closure of surgical wounds

Sponsors & Collaborators

  • BioStat International, Inc.

    collaborator INDUSTRY

  • Advanced Medical Solutions Ltd.

    lead INDUSTRY

Principal Investigators

  • Alfredo Carbonnell, MD · Prisma Health-Upstate

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-08
Primary Completion
2024-03-19
Completion
2024-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04740775 on ClinicalTrials.gov